Clinical Trial Update: Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating hybrid C11-Choline PET/MR and mpMRI for staging prostate cancer has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• C11-Choline (Choline labeled with carbon-11)
• PET/MR (Positron emission tomography / magnetic resonance imaging)

Snippet

Sponsor: Mayo Clinic | Conditions: Prostate Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2021-02-08